Lupu R - Search Results

1

Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.

Tang CK, Perez C, Grunt T, Waibel C, Cho C, Lupu R. Tang CK, et al. Among authors: lupu r. Cancer Res. 1996 Jul 15;56(14):3350-8. Cancer Res. 1996. PMID: 8764133

2

The significance of heregulin in breast cancer tumor progression and drug resistance.

Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D, Tang C. Lupu R, et al. Breast Cancer Res Treat. 1996;38(1):57-66. doi: 10.1007/BF01803784. Breast Cancer Res Treat. 1996. PMID: 8825123 Review.

3

Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R. Atlas E, et al. Among authors: lupu r. Mol Cancer Res. 2003 Jan;1(3):165-75. Mol Cancer Res. 2003. PMID: 12556556 Free article.

4

Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines.

Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R, Martin MB. Saceda M, et al. Among authors: lupu r. Endocrinology. 1996 Oct;137(10):4322-30. doi: 10.1210/endo.137.10.8828492. Endocrinology. 1996. PMID: 8828492

5

Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.

Harris LN, Yang L, Tang C, Yang D, Lupu R. Harris LN, et al. Among authors: lupu r. Clin Cancer Res. 1998 Apr;4(4):1005-12. Clin Cancer Res. 1998. PMID: 9563896

6

Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.

Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SC, Lupu R. Hijazi MM, et al. Among authors: lupu r. Int J Oncol. 2000 Oct;17(4):629-41. doi: 10.3892/ijo.17.4.629. Int J Oncol. 2000. PMID: 10995872

7

Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.

Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N, Lupu R. Sepp-Lorenzino L, et al. Among authors: lupu r. Oncogene. 1996 Apr 18;12(8):1679-87. Oncogene. 1996. PMID: 8622888

8

Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells.

Grunt TW, Saceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H, Dittrich C. Grunt TW, et al. Among authors: lupu r. Int J Cancer. 1995 Nov 15;63(4):560-7. doi: 10.1002/ijc.2910630417. Int J Cancer. 1995. PMID: 7591267

9

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.

Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R. Tsai MS, et al. Among authors: lupu r. Oncogene. 2003 Feb 6;22(5):761-8. doi: 10.1038/sj.onc.1206130. Oncogene. 2003. PMID: 12569369

10

Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].

Staebler A, Sommers C, Mueller SC, Byers S, Thompson EW, Lupu R. Staebler A, et al. Among authors: lupu r. Breast Cancer Res Treat. 1994;31(2-3):175-82. doi: 10.1007/BF00666151. Breast Cancer Res Treat. 1994. PMID: 7881097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters